Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis

被引：0

作者：

Justin A. Edward

Kevin Josey

Gideon Bahn

Liron Caplan

Jane E. B. Reusch

Peter Reaven

Debashis Ghosh

Sridharan Raghavan

机构：

[1] University of Colorado School of Medicine,Division of Cardiology

[2] Rocky Mountain,Department of Veterans Affairs Eastern Colorado Healthcare System

[3] Regional VA Medical Center,Department of Biostatistics and Informatics

[4] Medicine Service (111),Department of Veterans Affairs

[5] Colorado School of Public Health,Division of Rheumatology

[6] Hines VA Hospital,Division of Endocrinology, Metabolism, and Diabetes

[7] University of Colorado School of Medicine,Division of Biomedical Informatics and Personalized Medicine

[8] University of Colorado School of Medicine,undefined

[9] Department of Veterans Affairs Phoenix VA Medical Center,undefined

[10] University of Colorado School of Medicine,undefined

[11] Colorado Cardiovascular Outcomes Research Consortium,undefined

来源：

Cardiovascular Diabetology | / 21卷

关键词：

Machine learning; Glycemic control; Subgroup effects; Heterogeneity; Type 2 diabetes;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] PREDICTORS OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG TYPE 2 DIABETES MELLITUS PATIENTS: A MACHINE LEARNING TIME-TO-EVENT ANALYSIS
Icten, Z.
Friedman, M.
Menzin, J.
VALUE IN HEALTH, 2022, 25 (07) : S291 - S292
[42] EFFECTS OF INTENSIVE BLOOD PRESSURE CONTROL ON CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES MELLITUS: THE ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES (ACCORD) BLOOD PRESSURE TRIAL
Grimm, R.
JOURNAL OF HYPERTENSION, 2010, 28 : E602 - E602
[43] Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study
Junyu Pei
Xiaopu Wang
Zeyu Pei
Xinqun Hu
Cardiovascular Diabetology, 22
[44] Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study
Pei, Junyu
Wang, Xiaopu
Pei, Zeyu
Hu, Xinqun
CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
[45] Time-Dependent Covariate Analysis of Hemoglobin Values on Risk of Major Adverse Cardiovascular Events in the ASCEND Trials
Obrador, Gregorio T.
Johansen, Kirsten L.
Waikar, Sushrut S.
Jha, Vivekanand
Correa-Rotter, Ricardo
Del Vecchio, Lucia
Cases, Aleix
Robertson, Michele
Mallett, Stephen
Bailey, Christine K.
Cobitz, Alexander R.
Singh, Ajay K.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 44 - 44
[46] THE EFFECT OF ADALIMUMAB ON RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS: A META-ANALYSIS OF RANDOMIZED TRIALS
Burmester, G.
Emery, P.
Signorovitch, J.
Williams, D.
Valdes, J.
Bao, Y.
Mulani, P. M.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 359 - 360
[47] An analysis from PROactive on the effects of pioglitazone on major adverse cardiovascular events (MACE) and myocardial infarction
Wilcox, R.
DIABETOLOGIA, 2006, 49 : 72 - 72
[48] IMPACTS OF BLOOD GLUCOSE CONTROL WITH NOVEL DIABETIC DRUGS ON MAJOR ADVERSE CARDIOVASCULAR EVENTS: META-REGRESSION ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Wang, Weiting
Cheng, Hao-Min
Chiang, Chern-En
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1823 - 1823
[49] Glycemic control and cardiovascular events in type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
Khraisal, Ahmad
Bahekar, Amol A.
Trivedi, Atul
AlJaghbeer, Eshraq
Molnar, Janos
Arora, Rohit
Khosla, Sandeep
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A355 - A355
[50] Glycemic Control and Cardiovascular Events in Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
Khraisat, Ahmad
Bahekar, Amol
Artin, Bassel
Bhuriya, Rohit
Al-Jaghbeer, Eshraq
Singh, Sarabjeet
Molnar, Janos
Khosla, Sandeep
Arora, Rohit
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A219 - A219

← 1 2 3 4 5 →